Yu Shyr
Yu Shyr
Verifierad e-postadress på vanderbilt.edu - Startsida
Titel
Citeras av
Citeras av
År
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
BD Lehmann, JA Bauer, X Chen, ME Sanders, AB Chakravarthy, Y Shyr, ...
The Journal of clinical investigation 121 (7), 2750-2767, 2011
38032011
Survival in BRAF V600–mutant advanced melanoma treated with vemurafenib
JA Sosman, KB Kim, L Schuchter, R Gonzalez, AC Pavlick, JS Weber, ...
New England Journal of Medicine 366 (8), 707-714, 2012
21602012
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers—smoking as a cause of oxidative damage
JD Morrow, B Frei, AW Longmire, JM Gaziano, SM Lynch, Y Shyr, ...
New England Journal of Medicine 332 (18), 1198-1203, 1995
16221995
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
MG Kris, BE Johnson, LD Berry, DJ Kwiatkowski, AJ Iafrate, II Wistuba, ...
Jama 311 (19), 1998-2006, 2014
11972014
Expansion of myeloid immune suppressor Gr+ CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang, LM DeBusk, K Fukuda, B Fingleton, B Green-Jarvis, Y Shyr, ...
Cancer cell 6 (4), 409-421, 2004
11272004
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation
E Montgomery, MP Bronner, JR Goldblum, JK Greenson, MM Haber, ...
Human pathology 32 (4), 368-378, 2001
9162001
Proteomic patterns of tumour subsets in non-small-cell lung cancer
K Yanagisawa, Y Shyr, BJ Xu, PP Massion, PH Larsen, BC White, ...
The Lancet 362 (9382), 433-439, 2003
7562003
Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention
H Mertz, V Morgan, G Tanner, D Pickens, R Price, Y Shyr, R Kessler
Gastroenterology 118 (5), 842-848, 2000
6932000
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor
AE Powell, Y Wang, Y Li, EJ Poulin, AL Means, MK Washington, ...
Cell 149 (1), 146-158, 2012
5612012
Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection
BD Lehmann, B Jovanović, XI Chen, MV Estrada, KN Johnson, Y Shyr, ...
PloS one 11 (6), e0157368, 2016
5452016
Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer
JJ Smith, NG Deane, F Wu, NB Merchant, B Zhang, A Jiang, P Lu, ...
Gastroenterology 138 (3), 958-968, 2010
4892010
Plasma cytokine levels predict mortality in patients with acute renal failure
EM Simmons, J Himmelfarb, MT Sezer, GM Chertow, RL Mehta, ...
Kidney international 65 (4), 1357-1365, 2004
4732004
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
TW Miller, BT Hennessy, AM González-Angulo, EM Fox, GB Mills, H Chen, ...
The Journal of clinical investigation 120 (7), 2406-2413, 2010
4672010
Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study
TA Ikizler, RL Wingard, J Harvell, Y Shyr, RM Hakim
Kidney international 55 (5), 1945-1951, 1999
4441999
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21 WAF1/CIP1 via C/EBPβ
R Chinery, JA Brockman, MO Peeler, Y Shyr, RD Beauchamp, RJ Coffey
Nature medicine 3 (11), 1233-1241, 1997
4371997
Nationwide trends in mastectomy for early-stage breast cancer
KL Kummerow, L Du, DF Penson, Y Shyr, MA Hooks
JAMA surgery 150 (1), 9-16, 2015
4212015
Significance of p63 amplification and overexpression in lung cancer development and prognosis
PP Massion, PM Taflan, SMJ Rahman, P Yildiz, Y Shyr, ME Edgerton, ...
Cancer research 63 (21), 7113-7121, 2003
3792003
Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC).
MG Kris, BE Johnson, DJ Kwiatkowski, AJ Iafrate, II Wistuba, SL Aronson, ...
Journal of Clinical Oncology 29 (18_suppl), CRA7506-CRA7506, 2011
3422011
Predictive measures of vascular access thrombosis: a prospective study
RE May, J Himmelfarb, M Yenicesu, S Knights, TA Ikizler, G Schulman, ...
Kidney international 52 (6), 1656-1662, 1997
3271997
Vascular access blood flow monitoring reduces access morbidity and costs
P Mccarley, RL Wingard, Y Shyr, W Pettus, RM Hakim, TA Ikizler
Kidney international 60 (3), 1164-1172, 2001
3122001
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20